文献速递呼吸道感染肺栓塞与肺血管病

COVID-19与SARS及H1N1流感肺部组织病理学比较:系统综述

Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review.
PubMed 文献 · Chest · 2020-10-07

该系统综述纳入26篇COVID-19(171例)、20篇H1N1(287例)和8篇SARS(64例)文献,比较肺部组织病理特征。COVID-19急性期弥漫性肺泡损伤(DAD)占88%,与H1N1(90%)和SARS(98%)相似;微血栓在COVID-19(57%)和SARS(58%)中较H1N1(24%)更常见。

要点

  • COVID-19、SARS和H1N1流感肺部病理均以DAD为主要表现。
  • COVID-19和SARS中微血栓报告率高于H1N1流感。
  • 微血栓的病理发现需进一步验证及其临床意义。

核心结论

  • DAD是COVID-19、H1N1流感和SARS肺部病理的主要组织学模式。
  • 微血栓在COVID-19和SARS中比H1N1流感更常被报告。

研究设计与样本

  • 系统综述,检索MEDLINE和PubMed截至2020年6月24日。
  • 纳入26篇COVID-19(171例)、20篇H1N1(287例)、8篇SARS(64例)文献。
  • 采用PRISMA-个体参与者数据指南进行分析。

主要发现

  • COVID-19急性期DAD报告率为88%。
  • H1N1流感DAD报告率为90%,SARS为98%。
  • COVID-19微血栓报告率为57%,SARS为58%,H1N1流感为24%。

临床怎么用

  • 提示COVID-19和SARS的肺病理中微血栓较常见,临床需关注抗凝策略。

局限性

  • 需未来工作验证微血栓的组织病理学发现,并阐明机制及与临床结局的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with severe coronavirus disease 2019 (COVID-19) have respiratory failure with hypoxemia and acute bilateral pulmonary infiltrates, consistent with ARDS. Respiratory failure in COVID-19 might represent a novel pathologic entity. RESEARCH QUESTION: How does the lung histopathology described in COVID-19 compare with the lung histopathology described in SARS and H1N1 influenza? STUDY DESIGN AND METHODS: We conducted a systematic review to characterize the lung histopathologic features of COVID-19 and compare them against findings of other recent viral pandemics, H1N1 influenza and SARS. We systematically searched MEDLINE and PubMed for studies published up to June 24, 2020, using search terms for COVID-19, H1N1 influenza, and SARS with keywords for pathology, biopsy, and autopsy. Using PRISMA-Individual Participant Data guidelines, our systematic review analysis included 26 articles representing 171 COVID-19 patients; 20 articles representing 287 H1N1 patients; and eight articles representing 64 SARS patients. RESULTS: In COVID-19, acute-phase diffuse alveolar damage (DAD) was reported in 88% of patients, which was similar to the proportion of cases with DAD in both H1N1 (90%) and SARS (98%). Pulmonary microthrombi were reported in 57% of COVID-19 and 58% of SARS patients, as compared with 24% of H1N1 influenza patients. INTERPRETATION: DAD, the histologic correlate of ARDS, is the predominant histopathologic pattern identified in lung pathology from patients with COVID-19, H1N1 influenza, and SARS. Microthrombi were reported more frequently in both patients with COVID-19 and SARS as compared with H1N1 influenza. Future work is needed to validate this histopathologic finding and, if confirmed, elucidate the mechanistic underpinnings and characterize any associations with clinically important outcomes.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Hariri LP, North CM, Shih AR, et al. Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review. Chest. 2020. PMID: 33038391. doi:10.1016/j.chest.2020.09.259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。